| Clinical islet transplantation: is the future finally now? |
16 |
| Donation after circulatory death and its expansion in Spain |
16 |
| Drug-resistant cytomegalovirus: clinical implications of specific mutations |
13 |
| Recent progress in porcine islet isolation, culture and engraftment strategies for xenotransplantation |
11 |
| The need and opportunity for donation after circulatory death worldwide |
11 |
| Regulatory dendritic cells: profiling, targeting, and therapeutic application |
10 |
| Chronic rejection in vascularized composite allotransplantation |
9 |
| Laparoscopic right hepatectomy for living donor |
9 |
| Regulatory B cells and transplantation: almost prime time? |
8 |
| Emerging role of exosomes in allorecognition and allograft rejection |
8 |
| Current status and future direction of uterus transplantation |
8 |
| Delayed graft function in kidney transplantation |
8 |
| Xenogeneic transplantation and tolerance in the era of CRISPR-Cas9 |
7 |
| Progress and challenges in lung xenotransplantation: an update |
7 |
| Lung donation after circulatory death |
7 |
| Ex-vivo machine perfusion for kidney preservation |
7 |
| The dawn of liver perfusion machines |
6 |
| Current status of graft-versus-host disease after intestinal transplantation |
6 |
| Lung bioengineering: advances and challenges in lung decellularization and recellularization |
6 |
| Management of intestinal failure in middle-income countries, for children and adults |
6 |
| Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus |
6 |
| Ex-vivo lung perfusion and ventilation: where to from here? |
6 |
| Contemporary management of hepatoblastoma |
5 |
| Conquering combined thoracic organ and liver transplantation: indications and outcomes for heart-liver and lung-liver transplantation |
5 |
| Nonalcoholic steatohepatitis: the new frontier for liver transplantation |
5 |
| Pancreas transplantation in type 2 diabetes: expanding the criteria |
5 |
| The past, present, and future of costimulation blockade in organ transplantation |
4 |
| The clinical impact of donor-specific antibodies on antibody-mediated rejection and long-term prognosis after heart transplantation |
4 |
| Long-term care of transplant recipients: de novo neoplasms after liver transplantation |
4 |
| Impact of the microbiota on solid organ transplant rejection |
4 |
| Impact of extracellular vesicles on innate immunity |
4 |
| Current outcomes after pediatric and adult intestinal transplantation |
4 |
| Donor-specific antibody management in intestine transplantation: hope for improving the long-term durability of the intestine allograft? |
4 |
| Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way? |
4 |
| The future of HIV Organ Policy Equity Act is now: the state of HIV plus to HIV plus kidney transplantation in the United States |
4 |
| Current state of organ transplant tolerance |
4 |
| Updates on antiviral drugs for cytomegalovirus prevention and treatment |
4 |
| Nonhuman leukocyte antigen antibodies that have impact in the heart transplant patient |
4 |
| Pediatric lung transplantation: supply and demand |
4 |
| Current challenges and opportunities in the management of antibody-mediated rejection in lung transplantation |
4 |
| Single vs. bilateral lung transplantation: when and why |
4 |
| Cryopreservation by vitrification: a promising approach for transplant organ banking |
4 |
| Taking regulatory T-cell therapy one step further |
4 |
| Mechanisms of rejection in vascular composite allotransplantation |
4 |
| Organoids for replacement therapy: expectations, limitations and reality |
4 |
| The high-end range of biliary reconstruction in living donor liver transplant |
4 |
| Novel immunological and clinical insights in vascularized composite allotransplantation |
4 |
| Chimeric xenotransplantation |
3 |
| Advances in machine perfusion, organ preservation, and cryobiology: potential impact on vascularized composite allotransplantation |
3 |
| Mimicking nature-made beta cells: recent advances towards stem cell-derived islets |
3 |
